Related references
Note: Only part of the references are listed.Histologic Evolution From Adenocarcinoma to Squamous Cell Carcinoma After Gefitinib Treatment
Min-Shu Hsieh et al.
ANNALS OF THORACIC SURGERY (2015)
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor
Justine L. Kuiper et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J. Niederst et al.
NATURE COMMUNICATIONS (2015)
EGFR-Mutated Lung Cancer With T790M-Acquired Resistance in the Brain and Histologic Transformation in the Lung
Kevin S. Scher et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2013)
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports
Takehito Shukuya et al.
CANCER SCIENCE (2011)
Share Paper
